XAIR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Beyond Air Inc (XAIR) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. Despite significant revenue growth, the company faces financial challenges, including negative EPS, declining gross margins, and a bearish technical trend. The lack of strong trading signals and neutral sentiment from hedge funds and insiders further supports a cautious approach.
The technical indicators suggest a bearish trend. The MACD is below zero and negatively contracting, the RSI is neutral at 28.648, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 1.211 and 1.282, while support levels are at 0.983 and 0.913. The stock has a 90% chance of declining by -1.87% in the next day and -4.38% in the next month.
Revenue surged by 105.6% YoY in Q3 to $2.2M, driven by strong demand for the LungFit PH product.
The company maintains a robust cash position of $22.3M.
Analysts have a Buy rating with a $5 price target, indicating potential upside.
Q3 GAAP EPS of -$0.85 missed expectations, reflecting continued financial struggles.
Gross margin dropped significantly to -16.39%, down 87.93% YoY.
Leadership changes with a new CFO and interim CFO may introduce strategic uncertainty.
Stock trend analysis indicates a high probability of short-term and medium-term declines.
In Q3 2025, revenue grew by 105.6% YoY to $2.2M, but net income dropped to -$7.94M, and EPS fell to -$0.85. Gross margin declined significantly to -16.39%, highlighting operational inefficiencies. The company has a strong cash position of $22.3M, which may support future operations.
Rodman & Renshaw initiated coverage with a Buy rating and a $5 price target on January 20, 2026. However, the stock's current price of $1.12 suggests a substantial gap to the target, reflecting potential upside but also significant risks.
